Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by skys1on Jul 04, 2019 7:34pm
78 Views
Post# 29888100

RE:RE:RE:RE:RE:RE:Incentives to have a 1st cohort (UHN) 3-month data publish

RE:RE:RE:RE:RE:RE:Incentives to have a 1st cohort (UHN) 3-month data publishHey, Claridge(bencro) don't start your insults and name calling as is your standard want! You got kicked off this board before for it, keep it up and it will happen again as you richly deserve. I don't blame others or whine. I stated a real short coming of this management team, as I believe it is one of the reasons then SP isn't as high as I believe it should be, considering the considerable achievements of their technical team. That's not whining. It is voicing a real and experienced option. Lastly I have been trading financial instruments for 54 years including futures, stocks, bonds, & options so I don't need any of your less than experienced advice informing me there is no risk in a penny stock that has zero cash reserves or positive revenue stream. What happens if the company gets hit by the OSC again, or something serious happens to one of it's patients or any one of a dozen other occurrences that could result in the stock dropping in half again or more, so keep your financial advice to yourself. Advice like that I surely don't need.
Bullboard Posts